IMPROVING OUTCOMES IN MDS/MPN: TREOSULFAN-BASED CONDITIONING FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Bruno, Alessandro [1 ]
Lazzari, Lorenzo [1 ]
Diral, Elisa [1 ]
Mastaglio, Sara [1 ]
Clerici, Daniela [1 ]
Marktel, Sarah [1 ]
Lunghi, Francesca [1 ]
Piemontese, Simona [1 ]
Sannipoli, Daniele [1 ]
Gariazzo, Camilla [1 ]
Scorpio, Gianluca [1 ]
Bergonzi, Gregorio [1 ]
Corti, Consuelo [1 ]
Carrabba, Matteo Giovanni [1 ]
Bernardi, Massimo [1 ]
Vago, Luca [1 ]
Lupo-Stanghellini, Teresa [1 ]
Ciceri, Fabio [1 ,2 ]
Peccatori, Jacopo [1 ]
Greco, Raffaella [1 ]
机构：
[1] IRCCS Osped San Raffaele, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P151
引用
收藏
页码：248 / 248
页数：1
相关论文
共 50 条
  • [41] Treosulfan-based myeloablative conditioning prior to allogeneic hematopoietic cell transplantation is associated with reduced toxicity without increased risk of relapse.
    Giebel, S
    Wojnar, J
    Krawczyk-Kulis, M
    Wylezol, I
    Markiewicz, M
    Kruzel, T
    Holowiecki, J
    BLOOD, 2004, 104 (11) : 326A - 326A
  • [42] Treosulfan in combination with fludarabine as part of conditioning treatment prior to allogeneic hematopoietic stem cell transplantation
    Ussowicz, M.
    DRUGS OF TODAY, 2020, 56 (06) : 389 - 403
  • [43] Treosulfan plus fludarabine - encouraging conditioning for allogeneic hematopoietic stem cell transplantation in multiple myeloma
    Afram, G.
    Nahi, H.
    Liwing, J.
    Heeg, B.
    Mattsson, J.
    LeBlanc, K.
    Bjorkstrand, B.
    Gahrton, G.
    Ljungman, P.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S592 - S592
  • [44] Conditioning with treosulfan and fludarabine for allogeneic blood stem cell transplantation
    Casper, J
    Steiner, B
    Wolff, D
    Kleine, HD
    Wilhelm, S
    Hammer, U
    von Wurmb, N
    Roeber, S
    Wegener, R
    Freund, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S285 - S286
  • [45] Comparative evaluation of the predictive power of the EBMT risk score and the Hematopoietic Cell Transplantation Co-morbidity Index for allogeneic haematopoietic stem cell transplantation in a treosulfan-based conditioning setting
    Lupo-Stanghellini, M. T.
    Sala, E.
    Crotta, A.
    Marcatti, M.
    Assanelli, A.
    Carrabba, M.
    Marktel, S.
    Camba, L.
    Lunghi, F.
    Corti, C.
    Bernardi, M.
    Peccatori, J.
    Ciceri, F.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S353 - S353
  • [46] Fludarabine and treosulfan conditioning for allogeneic stem cell transplantation (SCT) in patients with AML and MDS not eligible for standard myeloablative conditioning: the role of treosulfan dose
    Shimoni, A.
    Peccatori, J.
    Shem-Tov, N.
    Lo Russo, A.
    Yerushalmi, R.
    Bernardi, M.
    Nagler, A.
    Ciceri, F.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S220 - S220
  • [47] FLUDARABINE AND TREOSULFAN CONDITIONING FOR ALLOGENEIC STEM-CELL TRANSPLANTATION IN PATIENTS WITH AML AND MDS NOT ELIGIBLE FOR STANDARD MYELOABLATIVE CONDITIONING
    Shimoni, A.
    Crotta, A.
    Shem-Tov, N.
    Peccatori, J.
    Yerushalmi, R.
    Bernardi, M.
    Nagler, A.
    Ciceri, F.
    HAEMATOLOGICA, 2012, 97 : 177 - 177
  • [48] Treosulfan-Based Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Myelodysplastic Syndrome (MDS): Promising Survival Outcome Including Patients with High-Risk Disease
    Floeth, Matthias
    Beckmann, Elena
    Reicherts, Christian
    Marx, Julia
    Call, Simon
    Shaforostova, Inna
    Esseling, Eva
    Albring, Jorn
    Mikesch, Jan-Henrik
    Schliemann, Christoph
    Lenz, Georg
    Stelljes, Matthias
    BLOOD, 2022, 140 : 7587 - 7588
  • [49] Treosulfan-based preparative regimen for allogeneic hematopoietic stem cell transplantation in children with increased risk of conventional regimen toxicity.
    Wachowiak, J
    Chybicka, A
    Kowalczyk, J
    Grund, G
    Boruczkowski, D
    Gorczynska, E
    Wojcik, B
    Leda, M
    Turkiewicz, D
    Drabko, K
    BLOOD, 2005, 106 (11) : 500A - 501A
  • [50] Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells
    Cieri, Nicoletta
    Greco, Raffaella
    Crucitti, Lara
    Morelli, Mara
    Giglio, Fabio
    Levati, Giorgia
    Assanelli, Andrea
    Carrabba, Matteo G.
    Bellio, Laura
    Milani, Raffaella
    Lorentino, Francesca
    Stanghellini, Maria Teresa Lupo
    De Freitas, Tiago
    Marktel, Sarah
    Bernardi, Massimo
    Corti, Consuelo
    Vago, Luca
    Bonini, Chiara
    Ciceri, Fabio
    Peccatori, Jacopo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (08) : 1506 - 1514
12345